Xenos Mason, MD, a neurologist specializing in movement disorders, provides commentary on an early-stage study evaluating induced pluripotent stem cells for patients with Parkinson disease.
Xenos Mason, MD
Advertisement
Articles by Xenos Mason, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA PDUFA Watch: Neurology Decisions to Track Through Late September
2
FDA Approves Orexin Agonist Oveporexton for Narcolepsy Type 1
3
Understanding the Gut-Brain Connection in Parkinson Disease: Laurie Sanders, PhD
4
FDA Clears VoxNeuro's EEG-Based Cognitive Assessment Software
5